PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30354573-0	2018	Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction beta-Blocker Utilization, Adherence, and Rehospitalization.	Metoprolol	12-22	solute carrier family 35 member G1	Homo sapiens	52-56	
30354573-12	2018	CONCLUSIONS: The nationwide metoprolol extended release shortage in the United States was associated with fewer patients receiving any long- or short-acting beta-blocker post-MI and lower adherence to beta-blocker therapy for those who did receive it, but did not appear to appreciably affect clinical outcomes at the population level.	Metoprolol	28-38	solute carrier family 35 member G1	Homo sapiens	170-174	
16505178-0	2006	Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.	Metoprolol	78-88	solute carrier family 35 member G1	Homo sapiens	29-33	
12504644-3	2003	STRUCTURE OF STUDY: The Prevention of Syncope Trial (POST) is a multicentre, randomized, placebo-controlled, study of metoprolol in the prevention of vasovagal syncope.	Metoprolol	118-128	solute carrier family 35 member G1	Homo sapiens	53-57